Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops-Reference-Cited by-同舟云学术

Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops

Published:2014-11-14 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Moscoso Carlos G.,Xing Li,Hui Jinwen,Hu Jeffrey,Kalkhoran Mohammad Baikoghli,Yenigun Onur M.,Sun Yide,Paavolainen Lassi,Martin Loïc,Vahlne Anders,Zambonelli Carlo,Barnett Susan W.,Srivastava Indresh K.,Cheng R. Holland

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep07025.pdf

Reference66 articles.

1. Lifson, J., Coutre, S., Huang, E. & Engleman, E. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med 164, 2101–2106 (1986).

2. Pinter, A. et al. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol 63, 2674–2679 (1989).

3. Moscoso, C. G. et al. Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding. Proc Natl Acad Sci U S A 108, 6091–6096, 10.1073/pnas.1016113108 (2011).

4. Stamatatos, L., Wiskerchen, M. & Cheng-Mayer, C. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry and replication. AIDS Res Hum Retrov 14, 1129–1139 (1998).

5. Barnett, S. W. et al. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J Virol 75, 5526–5540, 10.1128/JVI.75.12.5526-5540.2001 (2001).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies;Viruses;2023-05-09

2. Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology;Antibody Therapeutics;2022-01-01

3. Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category;Virology;2018-06

4. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys;Retrovirology;2018-03-09

5. Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism;PLOS ONE;2017-10-19